education and training - u-m school of public health · emily toth martin, mph phd, 03/2017 1 emily...

Emily Toth Martin, MPH PhD, 03/2017

1

Emily Toth Martin, MPH PhD Assistant Professor of Epidemiology

University of Michigan School of Public Health

Office: M5132 SPH II, Laboratory: 5657 SPH I 1415 Washington Heights, Ann Arbor, Michigan, 48109

Phone: (734) 647-4723; Email: [email protected] Website: themartinlab.com; Twitter: @MartinEpi

Education and Training University of Michigan 9/1997-4/2001 Bachelor of Science, Microbiology Major Field: Microbiology; Minor Field: Russian Language and Literature Research Scientist/Engineer 4/2001-9/2003 Department of Genome Sciences, Nickerson Laboratory University of Washington, Seattle WA University of Washington School of Public Health 10/2003-6/2005 Master of Public Health, Epidemiology Thesis: “A Pooled Analysis of Condom Effectiveness for Preventing HSV-2 Acquisition” Advisor: Anna Wald, MD, MPH Graduate Research Associate 10/2003-6/2005 Department of Laboratory Medicine, Wald Research Group University of Washington, Seattle, WA Clinical Research Associate 6/2005-6/2009 Division of Infectious Disease Seattle Children’s Research Institute, Seattle, WA University of Washington School of Public Health 10/2007-6/2009 Doctor of Philosophy, Epidemiology Dissertation: “Bocavirus in Young Children” Chair: Anna Wald, MD, MPH Postdoctoral Fellow 7/2009-9/2010 Division of Infectious Disease Seattle Children’s Research Institute, Seattle, WA Field: Infectious Disease Epidemiology

mailto:[email protected]


2

Academic Appointments Assistant Professor, Tenure-Track Rank achieved: 9/2010 Wayne State University Eugene Applebaum College of Pharmacy and Health Sciences Department of Pharmacy Practice, Detroit MI Assistant Professor, Tenure-Track Rank achieved: 9/2014 University of Michigan School of Public Health Department of Epidemiology, Ann Arbor, MI

Research Interests Epidemiology of respiratory viral infections; Impact of multiple pathogen infections; Use of vaccines and antivirals for prevention and treatment; Impact of chronic diseases on infectious disease risk and severity; Infection prevention in acute care settings.

Grants Present and Active Grants 1U01IP001034 (Martin, Monto). 7/2016-6/2021 CDC/NCIRD. Total Costs: $7,099,990 US Influenza Vaccine Effectiveness Network The goal of this project is to determine the yearly effectiveness of the seasonal influenza vaccine at preventing medically-attended acute respiratory illnesses in adults and children. This award includes funding for a longitudinal cohort of households which include young children to look at the impact of repeated infection and vaccination on the development of influenza-specific immunity over time. Dr. Martin is the Principal Investigator of this subcomponent in addition to being the Co-Principal Investigator on the core activities. Role: Co-Principal Investigator MCubed 2.0 (Martin, Herschensen, Stillwell). 4/2016-4/2017 Univ. Michigan. Total Costs: $60,000 The 2014 Enterovirus-D68 Epidemic: Clinical Outcomes and Host Gene Response The goal of this project is to determine the molecular epidemiology, clinical severity and associated host response of enterovirus and rhinovirus infections in adults and children hospitalized during the 2014 Enterovirus D-68 epidemic. Role: Principal Investigator (Multiple)


3

1U01P000974 (Martin, Monto). 8/2015-7/2020 CDC/NCIRD. Total Costs: $2,900,000 US Hospital Vaccine Effectiveness Network The goal of this project is to determine the effectiveness of influenza vaccine in preventing influenza-associated hospitalizations in adults. This award includes funding for the determination of the burden of respiratory syncytial virus among hospitalized adults. Dr. Martin is the Principal Investigator of this subcomponent. Role: Co-Principal Investigator K01AI099006 (Martin). 8/2012-7/2016. NIH/NIAID. Total Costs: $641,605 Defining Precursors to VRSA Emergence: Epidemiology of MRSA & VRE Dual Infection The goal of this project is to identify the predictors and outcomes of MRSA & VRE dual infection. This particular coinfection is a key precursor to VRSA emergence as well as a model for the study of co-infection patterns in adults with chronic comorbidities. Role: Principal Investigator Investigator-Initiated Study (Marchaim; PI of UM Subcontract: Martin). Clinell. Total Costs: $7,955 The Use of Cleaning Wipes in Reducing Environmental Contamination and Acquisitions of Multidrug Resistant Organisms and Hospital Acquired Infections. The goal of this project is to determine the effectiveness of novel cleaning wipes in a hospital environment. Role: Co-Investigator Previous Grant Support (reverse chronological order) Investigator-Initiated Contract (Monto, Malosh). 4/16-12/16. MUGAS. Total Costs: $32,000 Systematic Review of Randomized Pediatric Trials of Oseltamivir. The goal of this project is to evaluate the outcomes of children treated with oseltamivir through a pooled analysis of existing data. Role: Coinvestigator 1U01P000474-04 (Monto). 5/15-6/16 CDC/NCIRD. Total Costs: $4,904,315 Core plus Option A/B Proposal for Influenza Vaccine Effectiveness Research The goal of this project is to determine the yearly effectiveness of the seasonal influenza vaccine at preventing medically-attended acute respiratory illnesses in adults and children. This award includes funding for a longitudinal cohort of households which include young children to look at the impact of repeated infection and vaccination on the development of influenza-specific immunity over time. Role: Co-Investigator


4

Investigator-Initiated Research (Martin, Kaye). 6/14-5/15 Cubist Pharmaceuticals. Total Costs: $48,000 A retrospective cohort study of treatment outcomes in patients with ST131 versus non-ST131 ESBL-producing E. coli The goal of this project is to determine association between the molecular epidemiology of ESBL-producing E. coli and infection severity in hospitalized adults with chronic co-morbidities. Role: Co-Principal Investigator

Medical Education Grant (Kilgore). 1/13-6/14 Pfizer, Inc. Total Costs: $749,988 Pneumococcal Disease Prevention Initiative: Integrated Interventions for Improved Adult Immunization Rates. Role: Co-Investigator University Research Grant Program (Martin). 4/12-4/14 WSU Provost Office. Total Costs: $10,000 Development of a method to study the spread of vancomycin-resistant Enterococcus in households The goal of this project is to develop sampling and laboratory methods to enable community-level surveillance for vancomycin-resistant Enterococcus. Role: Principal Investigator

ASPIRE Award (Martin). 1/13-12/13 Pfizer, Inc. Total Costs: $95,153 Outcomes following Linezolid Therapy in Complicated Skin and Soft Tissue Infections: A Multi-Center Retrospective Study The goal of this project was to evaluate the pharmacoepidemiology and outcomes of skin and soft tissue infections and coinfections using large databases derived from multiple health systems in the greater Detroit area. Work included subanalyses of at risk patient groups, including patients with diabetes. Role: Principal Investigator Investigator-Initiated Proposal (Kaye). 11/11-12/13 Sage, Inc. Total Costs: $210,000 Bathing Hospitalized Dependent Patients with Disposable Washcloths Instead of Traditional Bath Basins The goal of this project was to evaluate the use of prepackages washcloths as an alternative to traditional patient bathing methods. Role: Epidemiology Lead Ralph E. Powe Junior Faculty Enhancement Award (Martin). 03/12-07/13 Oak Ridge Associated Universities. Total Costs: $10,000 Molecular Epidemiology of MRSA & VR-E. faecalis Isolated from Dual Infections The goal of this project was to determine the patient characteristics and molecular epidemiology of cases of MRSA – VRE dual infection.


5

Role: Principal Investigator New Investigator Award (Martin). 01/12-05/13 American Association of Colleges of Pharmacy. Total Costs: $9,999 Influenza & Obesity: A Prospective Study of Patient Outcomes and Antiviral Resistance The goal of this project was to characterize the association between obesity and severe influenza morbidity, including the development of antiviral resistance. Role: Principal Investigator

Faculty Research Award Program (Internal Competition) (Martin). 1/11-7/13 Wayne State University. Total Costs: $9,857 Determining Sequence Variation in Extended and Intermittent Human Bocavirus-1 Shedding The goal of this project was to develop and implement a Taqman assay to identify sequence heterogeneity in extended shedding events of human bocavirus in infants. Role: Principal Investigator

Early Career Award (Martin). 1/10-1/12 Thrasher Research Fund . Total Costs: $26,354 Role of human bocavirus infection in symptoms and severity of clinical disease in infants The goal of this project was to describe the symptoms of primary human bocavirus infection in infants. Role: Principal Investigator Pediatric Pilot Fund Award (Martin). 9/9-8/10 Seattle Children’s CCTR. Total Costs: $19,939 Natural History of Bocavirus in Young Infants The goal of this project was to establish a proof of concept testing strategy to use saliva samples for identification of primary human bocavirus infection in infants. Role: Principal Investigator Sponsored Contract (Martin, Zerr). 8/09-8/10 Vioguard, L.L.C. Total Costs: $70,000 Infection Control of Keyboards The goal of this project was to evaluate a novel UV-light system for keyboard cleaning. Role: Co-Principal Investigator Institute for Translational Health Sciences Small Pilot Grant Award (Englund). 5/08-5/09 University of Washington ITHS. Total Costs: $10,000 Development and Evaluation of a Novel Saliva Assay for Detection of Human Bocavirus The goal of this application was to develop a new saliva assay for use for non-invasive testing of human bocavirus infection. This work was proposed and conducted by Dr. Martin; the grant was submitted by Dr. Englund (mentor) due to institutional rules. Role: Co-Investigator


6

NIH Vaccine and Treatment Evaluation Unit (PI: Jackson, L; Subcontract PI: Englund, J). 1/08-12/13

NIH/NIAID. Total Costs: $2,000,000 The role of this NIH contract was to evaluate novel vaccine strategies and products. Role: Study coordinator for Seattle Children’s subcontract. Investigator-Initiated Research Program (Fairchok). 10/08-7/09 MedImmune, Inc. Total Costs: $200,000 Prospective Study of Viral Respiratory Tract Infections in Young Children Attending

Daycare The goal of this project was to determine the epidemiology of respiratory viral infections and coinfections in a longitudinal cohort of children attending daycare. Role: Analytical Lead Currently Submitted Grants U01 (Martin / Petrie) CDC. Total Costs: $1,479,592 Influenza Transmission in Community-Based Michigan Households The goal of the project is to determine the transmission rate of influenza in households through epidemiologic and molecular analyses and to describe the impact of non-influenza respiratory viruses on influenza susceptibility. Role: Principal Investigator R01 (Monto / Lauring) NIH/NIAID. Total Costs: $3,521,743 Molecular Characterization of Influenza Transmission in Vaccinated Households The goal of the project is to describe the molecular virology of influenza transmission among households with a high rate of vaccination and to determine specific antibody profiles among vaccinated individuals who become infection. Role: Coinvestigator CEIRS Program Option (Monto) NIH/NIAID. Total Costs: $1,481,152 Evaluating the Effect of Repeated Influenza Vaccination The goal of the project is to evaluate the impact of repeated influenza vaccine receipt on serologic correlates of protection. Role: Coinvestigator

Honors and Awards 2008 Selected presenter, Society for Epidemiologic Research PhD Student Workshop 2010 Thrasher Research Fund Early Career Award 2010 Research paper selected for editorial commentary in Journal of Infectious Dis. 2012 American Association of Colleges of Pharmacy New Investigator Award 2012 Ralph E. Powe Junior Faculty Enhancement Award


7

2012 ASPIRE Award in Antibacterial Research, Pfizer Inc. 2015 Research paper selected as “Editor’s Choice” in Journal of Infectious Diseases 2015 Macrae Foundation Young Investigator Award

Memberships in Professional Societies Society for Epidemiologic Research Infectious Disease Society of America Society for Healthcare Epidemiology of America Pediatric Infectious Diseases Society

Editorial Positions, Boards, and Peer-Review Service 2014-2017 Editorial Board, American Journal of Infection Control 2016 - Editorial Board, Open Forum Infectious Diseases Ad Hoc Peer Review Journal of Clinical Virology Emerging Infectious Diseases Influenza and Other Respiratory Viruses American Journal of Epidemiology American Journal of Infection Control Clinical Infectious Diseases Journal of Medical Virology PlosONE BMC Infectious Diseases Pediatric Infectious Disease Journal Vaccine Eurosurveillance

Grant Peer Review 2012 Grant Reviewer for PCORI program (Phase I) 2016 Grant Reviewer for US Army Medical Research and Material Command

(Preapplication) 2016 December, Study Section Member for US Army Medical Research and

Material Command

Teaching Didactic Courses School of Public Health, University of Michigan 2016-present EPID545 Molecular Technologies, 3 credits 2016-present EPID543 Virus Diseases, 3 credits 2015-present EPID582 Molecular Epidemiology, 3 credits


8

Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University 2012-2014 PPR6290 Population-based Medication Management, 3 credits. (Co-taught 2012-2013) 2012, 2014 PHA3040 Medical Informatics (Co-taught all years) Department of Midwifery, Bastyr University 2009 Introduction to Epidemiology

Independent study and facilitated learning Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University 2011-2012 PPS: Problem Based Learning Facilitator 2012-2014 Summer Directed Study Research Program (6 students in 2012, 19

students in 2013, 2 students in 2014) Postdoctoral Trainees and Fellows Timothy Kaeslitz UM Medical School 2016-2017 Doctoral Students Hannah Segaloff UM SPH Epidemiology 2015-current Chair Khalil Chedid UM SPH Epidemiology 2014-current Chair Derek Samarian UM SPH Epidemiology 2016-current Committee Member Masters Students Andrew Miller UM SPH Epidemiology 2016-current Capstone Advisor Jessica Plemmons UM SPH Epidemiology 2016-current Capstone Advisor Aslynn Cummings UM SPH Epidemiology 2016-current Capstone Advisor Tiffany Pham UM SPH Epidemiology 2016-current Capstone Advisor Samantha Harris UM SPH Epidemiology 2016-current Capstone Advisor Katherine Hanslits UM SPH Epidemiology 2015-current Capstone Advisor Maria Konja UM SPH Epidemiology 2015-current Capstone Advisor Anastashia Magee UM SPH Epidemiology 2015-current Capstone Advisor Courtney Strickland Georgia Tech 2016 Thesis Committee Amy Callear UM SPH Epidemiology 2015-2016 Capstone Advisor Ankita Badhwar UM SPH Epidemiology 2015-2016 Capstone Advisor Anne Messer UM SPH Epidemiology 2015-2016 Capstone Advisor Kathryn Sutcliffe UM SPH Epidemiology 2014-2016 Capstone Advisor Yuan Xin UM SPH Epidemiology 2014-2015 Capstone Advisor Pansy Awasthy WSU Pharm Sciences 2013-2015 Thesis Advisor Poorva Divekar WSU Pharm Sciences 2012-2014 Thesis Advisor Sudha Mudumana WSU Public Health 2013 Thesis Advisor


9

Undergraduate Students Andreea Taran UM Microbiology 2016-current Supervisor and Mentor Michelle Azar UM Microbiology 2016-current Supervisor and Mentor Jesse Kim UM Microbiology 2015-current Supervisor and Mentor Sydney Foote UM Microbiology 2015-current Supervisor and Mentor Mariam Akhtar UM Anthropology 2015-2016 Supervisor and Mentor Matthew Compton WSU Biology 2012-2014 Supervisor and Mentor Linda Arrabi WSU Biology 2013-2014 Supervisor and Mentor

Committee, Organizational, and Volunteer Service Institutional 2015-2017 Department of Epidemiology Recruitment Committee, UM 2014-2015 Department of Epidemiology Masters Curriculum Committee, UM 2013-2014 Pharmacy Practice Search Committee (2), WSU 2013-2014 Curricular Revision and Assessment, Dept of Pharmacy Practice, WSU 2011-2014 Pharmaceutical Sciences Search Committee (2), WSU 2011-2014 Pharmacy Assessment Committee, Division of Pharmacy, WSU 2011-2014 Graduate Program Task Force, Dept of Pharmacy Practice, WSU 2011-2012 Social Administrative Sciences Task Force, Division of Pharmacy, WSU 2011 Conference Program Committee – Antimicrobial Resistance; Management

Prevention and Therapeutic Strategies National 2016-present Member, Data Safety Monitoring Board, DSMB Protocol 16-0117 2016-2019 Member, Education Committee, Society for Healthcare Epidemiology in

America 2012-2015 Member and regular newsletter contributor, Society for Healthcare

Epidemiology in America Journal Club 2014 Abstract Reviewer for Society for Epidemiology Research Annual Meeting 2013-2014 Member, Graduate Program Committee, Social and Administrative

Sciences Section, American Association of Colleges of Pharmacy 2013-2014 Member, Membership Survey Analysis/Assessment Committee, American

Association of Colleges of Pharmacy 2013 Abstract Reviewer for AACP Annual Meeting, SAS Section Volunteer Service 2016 Science Olympiad Coach, Bryant Elementary 2nd grade, Ann Arbor, Michigan Media Interviews NPR “Issues of the Environment” (Radio Interview), BBC World News Service (Radio Interview), Medpage Today, Travel Weekly, Medscape, Metro World News, Infectious Diseases News


10

Invited Presentations 1. September 2, 2004 – Fred Hutchinson Cancer Research Center, Seattle, WA –

ID/Virology Research Conference. “Methods to Determine Relatedness of HSV-2 Infections.”

2. February 19, 2008 - Seattle Children’s Hospital, Seattle, WA - Research Staff Development Committee Brown Bag Seminar. “Respiratory Virus Quantity, Coinfections, and Illness Severity in Hospitalized Children.”

3. June 11, 2009 - Fred Hutchinson Cancer Research Center, Seattle, WA – ID/Virology Research Conference. “Bocavirus in Children: Beyond Nasal Swabs.”

4. August 20, 2009 – Seattle Children’s Hospital, Seattle, WA – Invited Speaker, Research Staff Development Committee Annual Research Symposium. “Working Together to Solve the Mystery of Bocavirus.”

5. November 13, 2009 – Center for Biostatistics in AIDS Research, Harvard School of Public Health. “Bocavirus and Childhood Respiratory Illness: Cause or Coincidence?”

6. October 23, 2009 – Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University. “Bocavirus and Childhood Respiratory Illness: Cause or Coincidence?”

7. February 15, 2011 – Wayne State University School of Medicine, Dept of Microbiology and Immunology, “Bocavirus and Respiratory Illness in Children: Cause or Coincidence?’

8. May 9, 2011 – Invited Plenary Speaker. 27th Clinical Virology Symposium, Pan American Society for Clinical Virology. “Bocaviruses and Human Disease: Not a Simple Cause and Effect”

9. September 8, 2011 – Wayne State University School of Medicine, Epidemiology Brown Bag “Epidemiology of Respiratory Virus Coinfections”

10. February 27, 2012 – Wayne State University School of Medicine, ID Fellows Didactic “Bocavirus”

11. November 14, 2013 – University of Michigan School of Public Health, Epidemiology Seminar “Not Just the Common Cold: The Epidemiology of Respiratory Virus Coinfections in Children”

12. February 3, 2014 – University of Michigan School of Public Health, Epidemiology Seminar “Epidemiology of Human Bocavirus-1 Primary Infection and Other Respiratory Virus Co-Detections”

13. November 6, 2014 – University of Michigan School of Public Health, Massab Vaccine Symposium Workshop “Do All Viruses Matter?”

14. November 30, 2015 - University of Michigan School of Public Health, Excellence in Research Symposium “Lightning Talk”

15. April 2, 2016 – Invited Speaker, XVIII Macrae Foundation Respiratory Virus Symposium, Lisbon, Portugal, “RSV and Coinfections”

16. June 11, 2016 – Invited Speaker, 43rd Annual Meeting, Association for Professionals in Infection Control and Epidemiology, Charlotte, NC. “Implications of Rapid Diagnostics”


11

17. July 27, 2016 – Invited Speaker, Washington State Hospital Association Safe Table, Seattle, WA. “Target: Diabetes – Diabetes and Risk of Surgical Site Infection”

18. July 29, 2016 – Invited Speaker, Seattle Children’s Hospital, Seattle WA. “The Genomic Toolbox: Using Molecular Epidemiology to Enhance Studies of Transmission and Severity”

19. August 16, 2016 – Invited Speaker, University of Michigan Pediatric Grand Rounds “Epidemiology of Respiratory Viruses in Childcare”

20. September 22, 2016 – Invited Speaker, Urban Center for Antimicrobial Resistance, Discovery, Education, and Stewardship (UCARDES) Symposium, Wayne State University “Whole genome sequencing to control MRSA antimicrobial resistance in Detroit”

Bibliography Peer-Reviewed Publications Students and trainees indicated with * 1. Wu X, Luke A, Rieder M, Lee K, Toth EJ, Nickerson D, Zhu X, Kan D, and Cooper

RS. An association study of angiotensinogen polymorphisms with serum level and hypertension in an African-American population. J Hypertension 2003, 21:1847-1852.

2. Martin ET, Koelle DM, Byrd B, Huang M, Vieira J, Corey L, and Wald A. Sequenced-based methods for identifying epidemiologically linked herpes simplex virus type 2 strains. J Clin Microbiol 2006, 44(7):2541-2546.

3. Kuypers J, Martin ET, Heugel J, Wright N, Morrow R, and Englund J. Clinical disease in children associated with newly described coronavirus subtypes. Pediatrics 2006, 119(1):e70-6.

4. Qin X, Galanakis E, Martin ET, Englund JA. Multi-target polymerase chain reaction for diagnosis of pertussis and its clinical implications. J Clin Microbiol 2007, 45(2):506-11.

5. Heugel JR, Martin ET, Kuypers J, Englund JA. Coronavirus-associated pneumonia in previously healthy children. Pediatr Infect Dis J 2007, 26(8):753-5.

6. Tasian SK, Park JR, Martin ET, Englund JA. Influenza-associated morbidity in children with cancer. Pediatr Blood Cancer 2008 May; 50(5):983-7.

7. Martin ET, Kuypers J, Heugel J, Englund JA. Clinical disease and viral load in children infected with respiratory syncytial virus or human metapneumovirus. Diagn Microbiol Infect Dis. 2008 Dec; 62(4)382-8.

8. Stempel HE, Martin ET, Kuypers J, Englund JA, Zerr DM. Multiple viral respiratory pathogens in children with bronchiolitis. Acta Paediatr 2009 Jan; 98(1):123-6.

9. Martin ET, Krantz E, Gottlieb SL, Magaret AS, Langenberg A, Stanberry L, Kamb M, Wald A. A pooled analysis of the effect of condoms in preventing HSV-2 acquisition. Arch Intern Med. 2009;169(13):1233-1240

10. Martin ET, Taylor J, Kuypers J, Magaret A, Wald A, Zerr D, Englund JA. Detection of bocavirus in saliva of children with and without respiratory illness. J Clin Microbiol. Dec 2009; 47(12):4131-4132.

11. Martin ET, Fairchok MP, Kuypers J, Magaret A, Zerr D, Wald A, Englund JA. Frequent and prolonged shedding of bocavirus in young children attending daycare.


12

J Infect Dis, 2010; 201(11):1625-1632. Editorial Commentary: Williams JV. Déjà vu all over again: Koch’s postulates and virology in the 21st century. J Infect Dis, 2010; 201(11):1611-1614.

12. Taylor JA, Weber WJ, Martin ET, McCarty RL, Englund JA. Development of a symptom score for clinical studies to identify children with a documented viral upper respiratory tract infection. Pediatr Res, 2010 Sep;68(3):252-257.

13. Fairchok MP, Martin ET, Chambers S, Kuypers J, Behrens M, Braun LE, Englund JA. Epidemiology of Viral Respiratory Tract Infections in a Prospective Cohort of Infants and Toddlers Attending Daycare. J Clin Virol 2010 Sep; 49(1):16-20. Epub 2010 Jul 21.

14. Martin ET, Kerin T, Christakis DA, Blume HK, Gospe SM, Vinje J, Bowen MD, Gentsch J, Zerr DM. Beyond febrile seizure: Redefining recurrence risk by symptoms of acute illness. Pediatrics. 2010 Dec; 126(6):e1477-84. Epub 2010 Nov 22.

15. Martin ET, Qin X, Baden H, Migita R, Zerr DM. Randomized double-blind crossover trial of UV light sanitized keyboards in a pediatric hospital. Am J Infect Control, 2011 Jun;39(5):433-5.

16. Fairchok MP, Martin ET, Kuypers J, Englund JA. A prospective study of parainfluenza virus type 4 infections in children attending daycare. Pediatr Infect Dis J, 2011 Aug; 30(8);714-6. Epub 2011 Feb 10.

17. Martin ET, Kuypers J, Wald A, Englund JA. Multiple Versus Single Virus Respiratory Infections: Viral Load and Clinical Disease Severity in Hospitalized Children, Influenza and Other Respi Viruses. 2012 Jan; 6(1):71-7. Epub 2011 May 31.

18. Pinelli NR, Jantz A, Martin ET, Jaber LA. Sensitivity and Specificity of Glycated Hemoglobin as a Diagnostic Test for Diabetes and Pre-Diabetes in Arab-Americans. J Clin Endocrinol Metab. 2011 Oct;8(10):679-86.

19. Marchaim D, Taylor AR, Hayakawa K, Bheemreddy S, Sunkara B, Moshos J, Chopra T, Abreu-Lanfanco O, Martin ET, Pogue JM, Lephart PR, Panda S, Dhar S, Kaye KS. Hospital bath basins are frequently contaminated with multidrug-resistant human pathogens. Am J Infect Control. Am J Infect Control. 2012 Aug;40(6):562-4. Epub 2011 Dec 16

20. Marchaim D, Perez F, Lee J, Bheemreddy S, Hujer AM, Rudin S, Hayakawa K, Lephart PR, Blunden C, Shango M, Campbell ML, Varkey J, Manickam P, Patel D, Pogue JM, Chopra T, Martin ET, Dhar S, Bonomo RA, Kaye KS. Swimming in resistance: Co-colonization with carbapenem-resistant Enterobacteriaceae and Acinetobacter baumannii or Pseudomonas aeruginosa. Am J Infect Control, 2012 Feb 10. [Epub ahead of print]

21. Braun LE, Renaud C, Fairchok MP, Kuypers J, Englund JA, Martin ET. Human parechovirus & other enteric viruses in childcare attendees in the era of rotavirus vaccines. J Peds Infect Dis Soc. 2012 1(2): 136-143.

22. Adler AL, Martin ET, Cohen G, Jeffries H, Gilbert M, Smith J, Zerr DM. A Comprehensive Intervention Associated with Reduced Surgical Site Infections among Pediatric Cardiovascular Patients, Including those with Delayed Closure. J Peds Infect Dis Soc. 2012 1(1): 35-43.


13

23. Ku K, BS, Pogue JM, Moshos J, Bheemreddy S, Wang Y, Bhargava A, Campbell M, Khandker N, Lephart PR, Chopra T, Hayakawa K, Martin ET, Abreu-Lanfranco O, Dhar S, Kaye KS, Marchaim D. Colistin versus tigecycline for the treatment of Acinetobacter baumannii and/or carbapenem resistant Enterobacteriaceae infections. American Journal of Infection Control 2012 Mar 21 [Epub ahead of print]

24. Hayakawa K, Marchaim D, Martin ET, Tiwari N, Sunkara B, Yousuf A, Pulluru H, Kotra H, Hasan A, Bheemreddy S, Sheth P, Lee D, Kamatam S, Bathina P, Nanjireddy P, Chalana I, Patel S, Kumar S, Vahia A, Ku K, Yee V, Swan J, Pogue J, Lephart P, Rybak M, Kaye K. “Comparison of the clinical characteristics and outcomes associated with vancomycin-resistant Enterococcus faecalis and vancomycin-resistant E. faecium bacteremia. Antimicrob Agents Chemother. 2012 May;56(5):2452-8. Epub 2012 Feb 12.

25. Martin ET, Tansek R, Collins V, Kayakawa K, Abreu-Lanfranco O, Chopra T, Lephart PR, Pogue JM, Kaye KS, Marchaim D. The CRE Score: a bedside score to rule out infection with carbapenem-resistant Enterobacteriaceae among hospitalized patients. Am J Infect Control 2013 Feb;41(2):180-2.

26. Stanaway JD, Wald A, Martin ET, Gottlieb SL, Magaret AS. Case-crossover analysis of condom use and herpes simplex virus type 2 acquisition. Sex Trans Dis. 2012 May; 39(5):388-93.

27. Hayakawa K, Marchaim D, Pogue JM, Ho K, Parveen S, Nanjireddy P, Sunkara B, Singla M, Jagadeesh KK, Moshos JA, Bommarito S, Mroue R, Farhat M, Obeid T, Chaudhry A, Vadlamudi G, Lephart PR, Martin ET, Rybak MJ, Kaye KS. Predictors and outcomes of linezolid-resistant vancomycin-resistant Enterococcus: a case-case-control study. Am J Infect Control 2012 Dec; 40(10):e261-3.

28. Judge T, Pogue JM, Marchaim D, Ho K, Kamatam S, Parveen S, Tiwari N, Ninjireddy P, Bheemreddy S, Biedron C, Mallikethi S, Reddy L, Khammam V, Chalana IK, Shekher PR, Martin ET, Rybak MJ, Kaye KS, Hayakawa K. Epidemiology of vancomycin-resistant enterococci with reduced susceptibility to daptomycin. Infect Control Hosp Epid 2012 Dec;33(12):1250-4.

29. Campbell ML, Marchaim D, Pogue JM, Sunkara B, Bheemreddy S, Bathina P, Pulluru H, Chugh N, Wilson MN, Moshos J, Ku K, Hayakawa K, Martin ET, Rybak MJ, Kaye KS. Treatment of methicillin-resistant Staphylococcus aureus infections with a minimal inhibitory concentration of 2µg/mL to vancomycin: old (trimethoprim/sulfamethoxazole) versus new (daptomycin or linezolid) agents. Ann Pharmacother.2012 Dec; 46(12):1587-97.

30. Gravett CA, Gravett MG, Martin ET, Bernson JD, Khan S, Boyle DS, Lannon SMR, Patterson J, Rubens CE, Steele MS. Serious and life-threatening pregnancy-related infections: opportunities to reduce the global burden. PLoS Med. 2012 Oct;9(10):e1001324 .

31. Kayakawa K, Marchaim D, Bathina P, Martin ET, Pogue JM, Sunkara B, Kamatam S, Ho K, Willis LB, Ajamoughli M, Patel D, Khan A, Lee KP, Suhrawardy U, Jagadeesh KK, Reddy SML, Levine M, Ahmed F, Omotola AM, Mustapha M, Moshos JA, Rybak MJ, Kaye KS. Independent Risk Factors for Co-colonization of Vancomycin-Resistant Enterococcus faecalis and Methicillin-Resistant Staphylococcus aureus in the region most endemic for Vancomycin-Resistant


14

Staphylococcus aureus isolation. Eur J Clin Micro Infect Dis. 2013 Jan 26 [Epub ahead of print].

32. Hayakawa K, Marchaim D, Palla M, Gudur UM, Pulluru H, Bathina P, Alshabani K, Govindavarjhulla A, Mallad A, Abbadi DR, Chowdary D, Kakarlapudi H, Guddati H, Das M, Kannekanti N, Vemuri P, Doddamani R, Mundra VRR, Guddeti RR, Policherla R, Baj S, Lohithaswa S, Shashidharan SP, Chidurala S, Diviti S, Sukayogula K, Joseph M, Pogue JM, Lephart PR, Martin ET, Rybak MJ, Kaye KS. Epidemiology of vancomycin-resistant Enterococcus faecalis: a case-case-control study. Antimicrob Agents Chem. 2013 Jan; 57(1): 49-55.

33. Martin ET, Fairchok MP, Stednick ZJ, Kuypers J, Englund JA. Epidemiology of Multiple Respiratory Viruses in Childcare Attendees. Journal of Infectious Diseases. J Infect Dis 2013 Mar; 207(6);982-9.

34. Chu HY, Kuypers J, Sarancino M, Wald A, Magaret A, Martin E, Fairchok M, Renaud C, Englund JA. Molecular Epidemiology of Respiratory Syncytial Virus Transmission in Childcare. J Clin Virol. 2013 Aug. 57(4):343-50.

35. Pogue JM, Marchaim D, Abreu-Lanfranco O, Sunkara B, Mynatt RP, Zhao JJ, Bhemreddy S, Hayakawa K, Martin ET, Dhar S, Kaye KS, Lephart PR. Fosfomycin activity versus carbapenem-resistant Enterobacteriaceae and vancomycin-resistant Enterococcus, Detroit, 2008-2010. J Antibiotics. 2013 Oct; 66(10): 625-7.

36. Martin ET, Archer C, McRoberts J, Kulik J*, Thurston T*, Lephart P, Kaye KS. Epidemiology of severe influenza outcomes among adult patients with obesity in Detroit, Michigan, 2011. Influenza and Other Resp Dis. 2013. 2013 Nov; 7(6): 1004-7.

37. Omotola AM, Li Y, Martin ET, Alshabani KA, Yadav D, Sarkar M, Thapa SD, Kumar V, Mahabashya A, Ahmad S, Bhargava A, Marchaim D, Pogue JP, Rybak MJ, Kaye KS, Hayakawa K. Risk factors for and epidemiology of community-onset vancomycin-resistant Enterococcus faecalis in Southeast Michigan. Am J Infect Control. 2013 Dec; 41(12): 1244-8.

38. Salinitri FD, Pinelli NR, Martin ET, Jaber LA. Insulin resistance and secretion in Arab Americans with glucose intolerance. Diabetes Technology and Therapeutics. 2013 Dec; 15(12): 1019-24.

39. Guiliano CA, Moser LR, Poremba V, Jones J, Martin ET, Slaughter R. Use of a unified learning style model in pharmacy curricula. Currents in Pharmacy Teaching and Learning. 2014; 41-57.

40. Miletic K*, Taylor T, Martin ET, Vaidya R, Kaye KS. Re-admissions after diagnosis of surgical site infection following knee and hip arthroplasty. Infect Control and Hosp Epid. 2014; 35(2):152-157.

41. Dhar S, Marchaim D, Tansek R, Chopra T, Yousuf A, Bhargava A, Martin ET, Talbot TR, Johnson LE, Hingwe A, Zuckerman JM, Bono BR, Shuman EK, Poblete J, Tran M, Kulhanek G, Thyagarajan R, Nagappan V, Herzke C, Perl TM, Kaye KS. Contact Precautions: More is not Necessarily Better. Infect Control and Hosp Epidemiology. 2014; 35 (3):213-221.

42. Hayakawa K*, Martin ET, Gudur UM, Marchaim D, Dalle D, Alshabani K, Muppavarapu KS, Jaidev F, Bathina P, Sundaragiri PR, Rajuri SD, Khatri J, Pogue J, Lephart P, Rybak MJ, Kaye KS. The impact of different antimicrobial therapies on


15

clinical and fiscal outcomes of patients with bacteremia due to vancomycin-resistant enterococci. Antimicrob Agents Chem. 2014 Jul; 58(7):3968-75.

43. Leibman V*, Martin ET, Tal-Jasper R, Grin L, Hayakawa K, Shefler C, Azouri T, Kaplansky T, Maskit M, Lazarovitch T, Zaidenstein R, Kaye KS, Marchaim D. Simple bedside score to optimize the time and decision to initiate appropriate therapy for carbapenem-resistant Enterobacteriaceae. Ann Clin Microbiol Antimicrob. 2015 Jun 4;14:31.

44. Martin ET, Kuypers J, McRoberts JP, Englund JA, Zerr DM. Human bocavirus-1 primary infection and shedding in infants. The Journal of Infectious Diseases, 2015 Aug 15;212(4):516-24 PMID: 25632039

45. Foxman B, Martin ET, Use of the Microbiome in the Practice of Epidemiology: A Primer on –Omic Technologies. Am J Epidemiology. 2015 Jul 1;182(1):1-8.

46. Martin ET, Kaye KS, Knott C*, Nguyen H*, Santarossa M*, Evans R, Beltran E*, Jaber L. Diabetes and Risk of Surgical Site Infection: A systematic review and meta-analysis. Infection Control & Hospital Epidemiology. 2016 Jan;37(1):88-99.

47. Chopra T, Marchaim D, Awali RA, Chalana I, Ahmed F, Martin ET, Sieggreen M, Sobel JD, Kaye KS. Risk factors and acute in-hospital costs for infected pressure ulcers among gunshot-spinal cord injury victims in southeastern Michigan. American Journal of Infection Control. 2016 Mar 1;44(3):315-9.

48. Gresh L, Kuan G, Sanchez N, Azziz-Baumgartner E, Ojeda S, Melendez M, Lopez R, Martin ET, Widdowson MA, Bresee J, Harris E, Balmaseda A, Gordon A. Burden of Influenza and Influenza-Associated Pneumonia in the First Year of Life in a Prospective Cohort Study in Managua, Nicaragua. Pediatric Infectious Disease Journal. 2016 Feb;35(2):152-6.

49. Dhar S, Martin ET, Lephart PR, McRoberts JP, Chopra T, Burger TT, Tal-Jasper R, Hayakawa K, Ofer-Friedman H, Lazarovitch T, Zaidenstein R, Perez F, Bonomo RA, Kaye KS, Marchaim D. Risk factors for carbapenem resistant Klebsiella pneumonia isolation stratified by multilocus sequence type (MLST): ST258 vs. non-ST258. Open Forum Infectious Diseases. 2016 Feb 12;3(1).

50. Karino S, Kaye KS, Navalkele B, Nishan B, Salim M, Solanki S, Pervaiz A, Tashtoush N, Shaikh H, Koppula S, Martin ET, Mynatt RP, Murray KP, Rybak MJ, Pogue JM. Epidemiology of Acute Kidney Injury Among Patients Receiving Concomitant Vancomycin and Piperacillin/tazobactam: Opportunities for Antimicrobial Stewardship. Antimicrobial Agents and Chemotherapy. 2016 May 23;60(6):3743-50.

51. Petrie JG, Ohmit SE, Cheng CK, Martin ET, Malosh RE, Lauring AS, Lamerato LE, Reyes KC, Flannery B, Ferdinands JM, Monto AS. Influenza Vaccine Effectiveness against Antigenically Drifted Influenza Higher than Expected in Hospitalized Adults: 2014-2015. Clinical Infectious Diseases. 2016 Oct 15;63(8):1017-25.

52. Navalkele B, Pogue JM, Karino S, Nishan B, Salim M, Solanki S, Pervaiz A, Tashtoush N, Shaikh H, Koppula S, Koons J, Hussain T, Perry W, Evans R, Martin ET, Mynatt RP, Murray KP, Rybak MJ, Kaye KS. Risk of Acute Kidney Injury in Patients on Concomitant Vancomycin and Piperacillin/tazabactam Compared to Those on Vancomycin and Cefepime. Clinical Infectious Diseases. 2016 Oct 20. In Press.


16

53. Evans R*, Loeb A*, Kaye KS, Cher ML, Martin ET. Infection-Related Hospital Admissions Following Prostate Biopsy in United States Men. Open Forum Infectious Diseases. In Press.

54. Sutcliffe K*, Kilgore PE, DeHoff K*, Evans R, Kaye KS, Malosh RE, Sherwin R, Martin ET. Survey of vaccination knowledge and acceptance among adults admitted to an urban emergency department. Vaccine. 2017 Feb 22;35(8):1148-1151.

55. Flannery B, Chung JR, Thaker SN, Monto AS, Martin ET, Belongia EA, McLean HQ, Gaglani M, Murthy K, Zimmerman RK, Nowalk MP, Jackson ML, Jackson LA, Foust A, Sessions W, Berman L, Spencer S, Fry A. Interim Estimates of 2016-17 Seasonal Influenza Vaccine Effectiveness – United States, February 2017. MMWR Morb Mortal Wkly Rep 2017;66(6):167-171.

56. Martin ET, Haider S, Palleschi M, Eagle S, Crisostomo DV, Haddox P, Harmon L, Mazur R, Moshos J, Marchaim D, Kaye KS. Bathing Hospitalized Dependent Patients with Pre-packaged Disposable Washcloths Instead of Traditional Bath Basins: A Case-Crossover Study. American Journal of Infection Control. In Press.

57. Monto AS, Malosh RE, Martin ET. The doctrine of original antigenic sin: separating good from evil. [Review] Journal of Infectious Diseases, In Press.

58. Jackson ML, Chung JR, Jackson LA, Phillips CH, Benoit J, Monto AS, Martin ET, Belongia EA, McLean HQ, Gaglani M, Murthy K, Zimmerman R, Nowalk P, Fry AM, Flannery B. Influenza vaccine effectiveness in the United States – 2015/16 season. New Engl J of Med. Accepted.

Non-Peer Reviewed Publications Invited Editorials 1. Martin ET. Neuraminidase Inhibitors for Treatment of Severe Influenza: Times are

Changing. Clinical Infectious Diseases. 2016 Nov 10. In Press

Letters to the Editor 1. Martin ET, Fairchok MP, Englund, JA. Reply to Longtin et al. J Infect Dis, 2010;

202(10); 1618. Other Media 1. “Is ‘Flu Day’ the new ‘Snow Day’?” Journal Club Article, SHEA Newsletter March

2012 2. “Antibiograms and Resistance” Journal Club Article, SHEA Newsletter April 2012 3. “The Known Unknowns: Respiratory viruses in asymptomatic children admitted to an

infant/toddler unit.” Journal Club Article, SHEA Newsletter July 2012 4. “Now you see it, now you don’t: Norovirus and elusive diagnoses of acute

gastroenteritis” Journal Club Article, SHEA Newsletter September 2012 5. “Splish Splash, Assessing the CHG Bath” Journal Club Article, SHEA Newsletter

November 2012. Also posted as: “Splish Splash, Preventing C Diff with the CHG Bath”, Expert Commentaries, Medscape News Today, December 4, 2012. http://www.medscape.com/viewarticle/775371


17

6. “O Come All Ye ESBL Carriers” Journal Club Article, SHEA Newsletter December 2012.

7. “Keep it Simple (and Objective): Development of Surveillance Definitions for VAP”, Journal Club Article, SHEA Newsletter January 2013

8. “It’s all in the ingredients: Meta-analysis of neuraminidase treatment in hospitalized patients with influenza”, Journal Club Article, SHEA Newsletter February 2013

9. “Making C. Difficile Less Difficult to ‘C’” Journal Club Article, SHEA Newsletter May 2013

10. “What’s Hitching a Ride on Your Gown and Gloves?” Journal Club Article, SHEA Newsletter June 2013

11. “Knowing is Half the Battle: Improving Antimicrobial Stewardship Training for Physicians” Journal Club Article, SHEA Newsletter September 2013. Also posted as Expert Commentaries, Medscape News Today

12. “Universal Gown and Glove Use: Proceed with Care” Journal Club Article, SHEA Newsletter November 2013

13. “An In-Depth Investigation of a Case of HIV Post-Exposure Prophylaxis Failure in a Healthcare Worker” Journal Club Article, SHEA Newsletter December 2013

14. “Don’t Give C. Diff a Hand” Journal Club Article, SHEA Newsletter February 2014 15. “I Can’t Get No Reaction: Lowered CLABSI Rates and No Adverse Events with

Chlorhexidine Bathing in Neonates” Journal Club Article, SHEA Newsletter March 2014

16. “Why Prescribe Today What You Can Prescribe Tomorrow: Strategies for Delayed Antibiotics for Respiratory Tract Illness” Journal Club Article, SHEA Newsletter April 2014

17. “A p value of 0.06? It’s not as close as you think!” Journal Club Article, SHEA Newsletter May 2014

18. “Time to Relax? Impact of Relaxing VRE Screening and Isolation Precautions” Journal Club Article, SHEA Newsletter August 2014

19. “Feeling Unheard?” Journal Club Article, SHEA Newsletter October 2014 20. “The More Things Change, the More They Stay the Same: Vancomycin

Susceptibility and Mortality” Journal Club Article, SHEA Newsletter December 2014 21. “Genetic detectives: How scientists use DNA to track disease outbreaks” The

Conversation, April 29, 2016. Reprinted by Business Insider. 22. Contributor to World Health Organization “Preferred Product Characteristics for Next

Generation Influenza Vaccines” Report. 2017.

Abstracts International, National, or Regional Refereed Meetings Students and trainees indicated with * 1. Toth EJ, Embuscado L, Huang M, Corey L, and Wald A. DNA Sequencing to

Determine Relatedness of HSV-2 Infections. Poster presentation, 2004 International Herpesvirus Workshop, Reno, Nevada.

2. Poole E, and Toth EJ. Adverse Maternal Outcomes in Pregnancy Among Underweight Women in Washington State. Poster presentation at the 2004 Washington State Joint Conference on Health, Wenatchee, Washington.


18

3. Martin ET, Kuypers J, Heugel J, Morrow, and Englund J. Quantitative Evaluation of Human Metapneumovirus Infection (hMPV) in Children. Oral presentation, 2006 Infectious Disease Society of America Annual Meeting, Toronto, Canada.

4. Martin ET, Kuypers J, Heugel J, Englund J. Importance of Respiratory Viral Coinfections in Hospitalized Children. Oral presentation, 2007 Infectious Disease Society of America Annual Meeting, San Diego, California.

5. Martin E, Adler A, Blume, H, Gentsch J, Christakis D, Berg A, Gospe S, Zerr D. Gastrointestinal Illness and First-time Seizures in Children. Poster presentation, 2008 41st Annual Society for Epidemiologic Research Meeting, Chicago, Illinois.

6. Martin ET, Kuypers J, Chambers S, Fairchok M, Englund JA. High Prevalence of Bocavirus in Young Children Attending Daycare. Poster presentation, 2008 Infectious Disease Society of America Annual Meeting, Washington, D.C.

7. Martin E, Adler A, Blume, H, Gentsch J, Christakis D, Berg A, Gospe S, Zerr D. Gastrointestinal Illness and First-time Seizures in Children. Poster presentation, 2008 62nd Annual American Epilepsy Society Annual Meeting, Seattle, Washington.

8. Martin ET, Taylor J, Kuypers J, Meier A, Wald A, Zerr D, Englund JA. Bocavirus Detections in Saliva of Asymptomatic and Symptomatic Children. Poster presentation, 2009 Infectious Disease Society of America Annual Meeting, Philadelphia, Pennsylvania.

9. Martin ET, Kuypers J, Wald A, Englund JA, Zerr D. Utilization of a New Salivary hBoV Assay to Study Prevalence and Persistence of hBoV Shedding in Young Infants. Oral presentation, 2010 Pediatric Academic Societies Meeting, Vancouver, Canada.

10. Martin ET, Kuypers J, Wald A, Starr JR, Englund JA, Zerr DM. Intermittent and Persistent Shedding of Human Bocavirus (HBoV) in Saliva of Young Infants. Oral presentation, 2010 Infectious Disease Society of America Annual Meeting, Vancouver, Canada.

11. Martin ET, Baden H, Migita R, Qin X, Zerr DM. Randomized double-blind crossover trial of UV light sanitized keyboards in a pediatric hospital. Poster presentation, 2010 Infectious Disease Society of America Annual Meeting, Vancouver, Canada.

12. Fairchok M, Martin E, Kuypers J, Englund JA, Chambers S. PIV-4 Infections in Young Children Attending Daycare. Poster presentation, 2010 Infectious Disease Society of America Annual Meeting, Vancouver, Canada.

13. Adler A, Martin E, Health J, Krengel W, Zerr D. Reducing Surgical Site Infections in Pediatric Patients Undergoing Spinal Fusions. Poster presentation, 2010 Infectious Disease Society of America Annual Meeting, Vancouver, Canada.

14. Chopra T, Satyaprakash S, Levine M, Chalana I, Ahmad F, Tamam Z, Panda S, Whittington S, Ruffin K, Singh K, Wang KY, Marchaim D, Hayakawa K, Sobel JD, Kaye KS, Taylor T, Martin ET. Cost of Pressure Ulcers in Gunshot Wound Victims with Paraplegia in Metro Detroit. Poster presentation, 2011 Society for Healthcare Epidemiology of America, Dallas, Texas.

15. Martin ET, Kuypers J, Wald A, Englund JA, Zerr DM. Acute Illness Symptoms Associated With Primary Human Bocavirus Infection In Infants (Poster). 2011 Epidemiology Congress, Montreal, Canada.


19

16. Martin ET, Fairchok MP, Kuypers J, Englund JA. Epidemiology of Respiratory Viral Coinfections in Daycare Attendees (Poster). 51st Interscience Conference on Antimicrobial Agent and Chemotherapy. 2011. Chicago, Illinois.

17. Martin ET, Marchaim D, Tansek R, Collins V, Kayakawa K, Abreu-Lanfranco O, Chopra TA, Pogue JM, Kaye KS. The “CRE Score”: A Bedside Score to Shorten the Time to Initiation of Effective Therapy for Carbapenem-Resistant Enterobacteriaceae (Poster). 51st Interscience Conference on Antimicrobial Agent and Chemotherapy. 2011. Chicago, Illinois.

18. Hayakawa K, Marchaim D, Gudur UM, Dalle D, Alshabani K, Mohin S, Jaydev F, Sundaragiri PR, Bathina P, Rajuri SD, Muppavarapu KS, Khatri JK, Lephart PR, Martin ET, Pogue JM, Rybak MJ, Kaye KS. The impact of different antimicrobial therapies on clinical and fiscal outcomes of patients with bacteremia due to vancomycin-resistant enterococci (Poster). 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy. 2012. San Francisco, California.

19. Martin ET, Casapao AM, McRoberts J, Archer C, Kaye K, Rybak M. Low prevalence of Inc18-like vanA plasmid among prospectively-collected vancomycin-resistant Enterococcus isolates from Detroit Medical Center (Poster). 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy. 2012. San Francisco, California.

20. Hayakawa K, Marchaim D, Palla M, Gudur UM, Pulluru H, Diviti S, Ajamoughi M, Khan A, Mallad A, Lee KP, Bathina P, Alshabani K, Govindavarjhulla A, Abbadi DR, Chowdary D, Kakarlapudi H, Guddati H, Das M, Guddeti RR, Plicherla R, Bai S, Lohithaswa S, Shashidharan SP, Chidurala S, Patel D, Pogue J, Lephart PR, Martin ET, Rybak MJ, Kaye KS. Epidemiology of and risk factors for vancomycin-resistant Enterococcus faecalis: a case-case-control study (Poster). IDWeek 2012, San Diego, California.

21. Martin ET, Alshabani K, Bhargava A, Yadav D, Srkar M, Thapa SD, Kumar V, Mahabashya A, Ahmad S, Marchaim D, Reye-Sachin C, Chopra T, Dhar S, Abreulanfranco O, Pogue JM, Rybak MJ, Kaye KS, Hayakawa K. The Effects of Severity Parameters of Diabetes Meillitus (DM) on Likelihood of Co-colonization of Vancomycin-Resistant E. faecalis and Methicillin-Resistant Staphylococcus aureus (MRSA) (Poster). IDWeek 2012, San Diego, California.

22. Martin ET, McRoberts J, Kuypers J, Englund JA, Zerr DM. Allelic Variation in Human Bocavirus-1 Isolates Collected Longitudinally from Infants (Poster). Poster Presentation at IDWeek 2012, San Diego, CA.

23. Beattie EL*, Martin ET. Internet analysis of alternative child immunization schedules (Poster). American College of Clinical Pharmacy Virtual Symposium, 2013.

24. Martin ET, Slaughter RS. Predictors of excellent graduating GPA and NAPLEX performance among PharmD students at Wayne State University. Poster Presentation. American Association of Colleges of Pharmacy Annual Meeting: Pharmacy Education 2013. Chicago, IL.

25. Beattie EL*, Martin ET. Internet analysis of reasons for alternative child immunization schedules. Poster Presentation. American Association of Colleges of Pharmacy Annual Meeting: Pharmacy Education 2013. Chicago, IL.

26. Martin ET, Archer C, Evans R, Biedron C*, Collins V, McRoberts JP, Thurston T*, Kulik J*, Arshad S, Kilgore P, Kaye KS. Influenza & Obesity: A prospective study of


20

patient outcomes and antiviral resistance (Poster). American Association of Colleges of Pharmacy Annual Meeting: Pharmacy Education 2013. Chicago, IL.

27. Leibman V*, Martin ET, Tal-Jasper R, Grin L, Azoury T, Tansek R, Collins V, Shefler C, Lazarovitch T, Kaye KS, Marchaim D. Simple bedside score to shorten the time to initiation of appropriate therapy for carbapenem-resistant Enterobacteriaceae (CRE) (Poster). 53nd Interscience Conference on Antimicrobial Agents and Chemotherapy. 2013. Denver, Colorado.

28. Sadasivan S, Zerr DM, Kilgore P, Martin ET. Seizure-associated hospital admissions of children in the United States in the post-rotavirus vaccination era. Michigan Epidemiology Conference, 2013. East Lansing, Michigan

29. Luther M, Martin ET, Maame A, Araba S, Colman J, Mylonakis E, LaPlante KL. Clonal lineage of Staphylococcal isolates related to biofilm production (Poster). 53nd Interscience Conference on Antimicrobial Agents and Chemotherapy. 2013. Denver, Colorado.

30. Archer C, Evans R, Davis SL, Pogue JM, Rybak MJ, Kaye KS, Martin ET. Decreasing MRSA prevalence among ABSSSI-associated hospitalization in the Detroit Metropolitan area, 2006-2012. 53nd Interscience Conference on Antimicrobial Agents and Chemotherapy (Poster). 2013. Denver, Colorado.

31. Martin ET, McRoberts JP, Divekar P*, Evans R, Hill B*, Archer C, Kaye KS, Rybak, MJ. Prevalence of pSK41 plasmid among patients with MRSA and VRE dual infection. 53nd Interscience Conference on Antimicrobial Agents and Chemotherapy (Poster). 2013. Denver, Colorado.

32. Martin ET, Kilgore PE, Zerr DM. Patterns of seizure-associated hospital admission in the United States before and after introduction of rotavirus vaccination (Poster). IDWEEK, 2013. San Francisco, California.

33. Vitkon-Barkay I, Yekutiel M, Martin ET, de Almeida KNF, Nestor D, Geva G, Wolfson Y, Azouri T, Kaye KS, Marchaim D. Developing a score to shorten the time to initiation of appropriate therapy for extensively drug resistant Gram-negative bacilli and avoid unnecessary use of polymixins (Poster). 2014. 24th European Society of Clinical Microbiology and Infectious Diseases. Barcelona, Spain.

34. Dhar S, Martin ET, McRoberts JP, Hayakawa K, Bheemreddy S, Lephart PR, Lazarovitch T, Kaye KS, Marchaim D. The epidemiology of carbapenem resistant Klebsiella pneumoniae stratified by multi-locus sequence typing (Poster). 2014. 24th European Society of Clinical Microbiology and Infectious Diseases. Barcelona, Spain.

35. Arrabi L*, Ben-Yehuda G, Burger T, McRoberts JP, Lephart P, Kaye KS, Martin ET, Mann T. Comparing Two Methods for Detection of Sepsis Pathogens: Roll Plate and Direct PCR (Poster). 2014 National Conference on Undergraduate Research. Lexington, Kentucky.

36. Evans R, Archer C, Jaber L, Kaye KS, Rybak M, Davis SL, Martin ET. Epidemiology of Polymicrobial Infections in Methicillin Resistant Staphylococcus aureus Associated Complicated Skin and Soft Tissue Infections (Poster). Society for Epidemiologic Research Annual Meeting, 2014. Seattle, Washington.

37. Martin ET, Knott C*, Nguyen H*, Santarossa M*, Kaye KS, Jaber L. A Systematic Review and Meta-Analysis of the Association between Diabetes Mellitus and


21

Surgical Site Infections (Poster). Society for Epidemiologic Research Annual Meeting, 2014. Seattle, Washington.

38. Martin ET, Nguyen H*, Santarossa M*, Knott C*, Conger E*, Kaye KS, Jaber L. A Systematic Review and Meta-Analysis of the Association between Hyperglycemia and Surgical Site Infections (Poster). American Diabetes Association’s 74th Scientific Sessions. San Francisco, California.

39. Haider S*, Moshos J, Marchaim D, Martin ET, Divine G, Kaye KS. The Impact of Bathing Hospitalized Dependent Patients with Disposable Washcloths Instead of Traditional Bath Basins on Infection Rates and Skin Condition (Poster). IDWeek. 2014. Philadelphia, PA.

40. Neelakanta A, Karino S, Tashtoush N, Martin ET, Kesani VP, Jackson J, Awasthy P*, Chevalier T, Dziekan B, Haider S, Bonomo R, Mynatt R, Pogue J, Robinson M, Flanagan E, Kaye KS, Dhar S. Outbreak of Colistin-Resistant Acinetobacter baumannii in Intensive Care Units in Detroit, Michigan (Poster). IDWeek 2014, Philadelphia, PA.

41. Martin EK, Kuypers J, Chu HY, Fairchok MP, Martin ET, Englund JA. Transmission of Human Rhinovirus Genotypes among Childcare Attendees (Poster). IDWeek. 2014. Philadelphia, PA.

42. Martin ET, Jones H*, Martin EK, Chu H.Y., Fairchok M, Kuypers J, Englund JA. Epidemiology and Persistence of Human Rhinovirus Infections in Childcare (Poster). IDWeek. 2014. Philadelphia, PA.

43. Evans RE, Loeb A, Cher ML, Kaye KS, Martin ET. Infection-related Hospital Readmissions Following Prostate Biopsy in United States Men (Poster). IDWeek. 2014. Philadelphia, PA.

44. Martin ET, Compton M*, Evans R, McRoberts JP, Arrabi L*, Pasha A*, Lephart P, Rybak MJ, Kaye KS. Molecular Epidemiology of MRSA and VRE Co-colonization among Hospitalized Adults in Detroit (Poster). IDWeek. 2014. Philadelphia PA.

45. Martin ET, Kuypers J, McRoberts JP, Englund JA, Zerr DM. Human bocavirus primary infection and shedding in infants (Symposium Presentation). XVII Respiratory Symposium, 2015 Vancouver, BC.

46. Compton M*, Arrabi L, Lephart P, Rybak MJ, Kaye KS, Martin ET. Molecular Epidemiology and pSK41 Prevalence Among Patients with MRSA-VRE Co-Colonization (Poster). National Conference on Undergraduate Research. 2015. Spokane, WA.

47. Pogue JM, Martin ET, Kaye KS, Marchaim D, Hayakawa K. Discordance in reported rates of nephrotoxicity associated with colistin: A systematic review to analyze the role of dose and definition. 25th European Congress of Clinical Microbiology and Infectious Diseases, 2015, Copenhagen, Denmark. (Presenting Author)

48. Martin ET, Awasthy P*, Marchaim D, Pogue J, Hayakawa K, Kaye KS. High prevalence of ST131 among extended spectrum β-lactamase producing E. coli among inpatients in the metropolitan Detroit area (Oral Presentation). 25th European Congress of Clinical Microbiology and Infectious Diseases, 2015, Copenhagen, Denmark.

49. Viau RA, Kaye K, Wagner TK, Walker T, Lephart P, Bonomo RA, Martin ET. Comparing Culture Based Methods To a Novel PCR-based Multiplex Assay to


22

Detect Carbapenemase Genes in Perirectal Swabs (Poster). 115th General Meeting of the American Society for Microbiology. 2015. New Orleans, LA.

50. Parente DM, Luther MA, Caffrey AR, Martin ET, Salzman EA, LaPlante KL. Molecular Predictors of Biofilm-Producing Staphylococcus aureus. Poster Presentation, 55nd Interscience Conference on Antimicrobial Agents and Chemotherapy 2015, Denver, CO.

51. Martin ET, Evans R, Archer C, Petrie J, Arshad S, Kaye KS. Influenza, obesity and timely administration of oseltamivir: a prospective study of patient outcomes. Poster Presentation. IDWeek 2015, San Diego, CA.

52. Martin ET, Evans R*, Compton M*, Pogue JM, Lephart P, Rybak MJ, Kaye KS, Davis SL. All-cause readmission following treatment with linezolid for MRSA-ABSSSI: a propensity score analysis. Poster Presentation. IDWeek 2015, San Diego, CA.

53. Petrie JG, Ohmit SE, Martin ET, Malosh RE, Cheng CK, Lamerato L, Lipkovich H, Fry AM, Ferdinands JM, Monto AS. Influenza vaccine effectiveness against antigenically drifted influenza higher than expected in hospitalized adults: 2014-2015. Late Breaker Oral Presentation. IDWeek 2015, San Diego, CA.

54. Heinze K, Martin ET, Kabeto M, Mody L. Caught in transition? Methicillin-resistant S. aureus & Vancomycin-resistant Enterococci Co-colonization among newly admitted Long Term and Post-Acute Care Residents. 26th European Congress of Clinical Microbiology and Infectious Diseases, 2016, Amsterdam, Netherlands.

55. Heinze K, Martin ET, Kabeto M, Mody L. Predictors of Methicillin-resistant S. aureus & Vancomycin-resistant Enterococcus Co-colonization among Long Term and Post-Acute Care Residents. 2016 Annual Scientific Meeting of the American Geriatrics Society, 2016, Long Beach, California.

56. Malosh RE, Callear A, Martin ET, Ohmit SE, Petrie JG, Lamerato L, Ferdinands J, Fry AM, Monto AS. Comparing hospitalization for acute respiratory illness due to influenza and respiratory syncytial virus among adults of all ages: 2014-2015. Options IX for the Control of Influenza, 2016, Chicago, Illinois.

57. Segaloff H, Petrie JG, Malosh RE, Cheng C, Ohmit SE, Ferdinands JM, Fry AM, Lauring AS, Lamerato L, Monto AS, Martin ET. Risk factors for severe morbidity among adults hospitalized with acute respiratory illness during the 2014-2015 influenza season. Options IX for the Control of Influenza, 2016, Chicago, Illinois.

58. Monto AS, Malosh RE, Lamerato LE, Lauring AS, Petrie JG, Callear A, Martin ET. RSV and Influenza in Hospitalized Adults. RSV16 Symposium, 2016, Bariloche, Argentina.

59. Martin ET, Callear A, Taran A, Malosh RE, Monto AS. Distinguishing household versus community-based transmission events using RSV type and sequencing. RSV16 Symposium, 2016, Bariloche, Argentina.

60. Hanslits K, Evans R, Konja M, Sutcliffe K, Kim J, Salim M, Salzman E, Kaye KS, Martin ET. Risk factors for MRSA-VRE coinfection among hospitalized adult. IDWeek 2016. New Orleans, Louisiana.

61. Malosh RE, Cheng CK, Martin ET, Ferdinands JM, Fry AM, Monto AS. Community Acquired Pneumonia (CAP) in adults hospitalized with ARI during the 2014-2015 influenza season: Participant characteristics and viral etiologies. IDWeek 2016. New Orleans, Louisiana.


23

62. Martin ET, Callear A, Taran A, Malosh RE, Monto AS. Identifying household transmission of RSV through subtyping and sequencing. Oral Presentation. Transmission of Respiratory Viruses 2017. Hong Kong.

63. Lauring AS, McCrone JT, Malosh R, Truscon R, Johnson E, Martin ET, Monto AS. Next generation sequencing of influenza viruses in a household cohort reveals an effective transmission bottleneck of close to one. Oral Presentation. Transmission of Respiratory Viruses 2017. Hong Kong.

education and training - u-m school of public health · emily toth martin, mph phd, 03/2017 1 emily...

Documents